Open AccessRaloxifene and Selective Cell Cycle Specific Agents: A Case for the Inclusion of Raloxifene in Current Breast Cancer Treatment Therapies
Author(s) -
Elizabeth B Fryar-Tita,
Jharna R. Das,
Jeffrey Davis,
JA Desoto,
Sídney Green,
William M. Southerland,
Donnell Bowen
Publication year - 2007
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/1f0w-7931
Subject(s) - raloxifene , breast cancer , selective estrogen receptor modulator , medicine , oncology , inclusion (mineral) , cancer , estrogen receptor , chemistry , mineralogy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom